SCIENTIFIC PUBLICATIONS

Our medical oncologists and laboratory investigators are at the forefront of investigations into the causes of cancer and the search for novel treatments.

We have published the results of our investigations, often in collaboration with some of the most prestigious international institutions, in renowned medical journals such as the New England Journal of Medicine, Clinical Cancer Research, and many others.

CONSULT OUR SCIENTIFIC PUBLICATIONS

07/12/2018

Publication Number: P5-11-04 Anti-proliferative effect of oral metronomic vinorelbine (mVNB) in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): A randomized, three-arm, window-of-opportunity study

AUTHORS Aleix Prat1,2,3, Barbara Adamo1 , Tomás Pascual1,2,3, José A Perez Fidalgo4 , Salvador Blanch5 , Noelia Martínez6 , Patricia Gomez Pardo7 , Ana Lopez Gonzalez8 , Laura Murillo Jaso9 , Kepa Amillano10, Maria Vidal1 , Laia Paré2,3, Jordi Canes2 , Patricia G

PUBLICATION P5-11-04 San Antonio Breat Cancer Symposium

07/12/2018

Publication Number: P5-13-05 Overcoming barriers to achieve a successful breast cancer patient recruitment: Professionals' views

AUTHORS Ana Casas1 , Xavier Gonzàlez2,3, Marta Capelán4 , Josefa Morales2 , Marta Fabián2 , Eva Ciruelos5 and Giovanna Gabriele6,7

PUBLICATION P5-11-04 San Antonio Breat Cancer Symposium

07/12/2018

Publication Number: PD3-03 SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer

AUTHORS Eva Ciruelos1,2, Patricia Villagrasa2 , Laia Paré2,3, Mafalda Oliveira4,2, Sonia Pernas5,2, Javier Cortés6 , Jesús Soberino4 , Barbara Adamo7 , Silvia Vazquez5 , Noelia Martínez6 , Antonia Perelló8 , Begoña Bermejo9 , Eduardo Martínez10, Isabel Garau11, M

PUBLICATION P5-11-04 San Antonio Breat Cancer Symposium

07/12/2018

Publication Number: PD3-06 Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer: Updated results from the phase 2 SUMMIT trial

AUTHORS Lillian M Smyth1 , Sarina A Piha-Paul2 , Cristina Saura3 , Sherene Loi4 , Janice Lu5 , Geoffrey I Shapiro6 , Dejan Juric7 , Ingrid A Mayer8 , Carlos Arteaga8 , Macarena de la Fuente9 , Adam M Brufksy10, Morten Mau-Sørensen11, Monica Arnedos12, Victor More

PUBLICATION P5-11-04 San Antonio Breat Cancer Symposium

07/12/2018

CORALLEEN: A phase 2 clinical trial of chemotherapy or letrozole plus ribociclib as neoadjuvant treatment for postmenopausal patients with luminal B/HER2-negative breast cancer

AUTHORS Joaquín Gavila1 , Cristina Saura2 , Mafalda Oliveira2 , Eva Ciruelos3 , Xavier Gonzalez4 , Lorena de la Peña5 , Begoña Bermejo de las Heras6 , Montserrat Muñoz7 , Pedro Fernandez7 , Patricia Villagrasa5 , Vanesa Ortega8 , Rafael Lopez9 , Pamela Celiz5 , T

PUBLICATION P5-11-04 San Antonio Breat Cancer Symposium